TSE:4967Personal Products
Assessing Kobayashi Pharmaceutical (TSE:4967) Valuation After Oasis Management’s Governance Challenge
Governance dispute focuses attention on Kobayashi Pharmaceutical
Oasis Management’s public campaign against Kobayashi Pharmaceutical (TSE:4967) and its move to a Company with an Audit and Supervisory Committee has pushed the company’s governance structure and board oversight firmly into the spotlight for shareholders.
See our latest analysis for Kobayashi Pharmaceutical.
The governance dispute has arrived after a period where the 90 day share price return of 7.41% contrasts with a weaker 3...